BackgroundIron is central to the aetiology of gastrointestinal disease. Specifically, the toxic effects of excess, unabsorbed 'luminal' iron ingested from the diet has been shown to be important in the development of inflammatory bowel disease and intestinal carcinogenesis. A platform for therapeutic intervention is likely to involve chelation of this 'luminal' pool of iron specifically without interfering with systemic iron. Therefore, a range of iron-chelating polymers, known as alginates, have been tested for their iron binding capacity. Alginates are natural, non-absorbable and non-fermentable bio-polymers which can therefore be employed to bind residual dietary colonic iron without becoming absorbed during gastro-intestinal transit.
Materials methodsThe structural and physicochemical properties of alginate-iron binding were assessed using high resolution scanning transmission electron spectroscopy (STEM) and circular dichroism spectroscopy. Cell lines were stimulated with iron in the presence and absence of sodium alginates (ManDH, ManLD, LFR, RF, GHB, PROT and KEL at 0.3% w/v) and effects on cellular iron levels were assessed using the radioactive ( 59 Fe) uptake assays and ferritin analysis. CACOII models of intestinal absorption were performed to examine the dynamics of iron trafficking through the cell monolayer when treated with alginates. Furthermore, In vivo studies were performed to 1) assess the potential of alginate solutions (8% w/v) to bind iron within the gastrointestinal tract by utilising radioactive iron and to 2) assess its potential anti-cancer activity. Results A range of alginates were utilised and their iron binding potential was assessed. The chemical interaction between alginate and iron was studied using STEM, which revealed alginate-supported iron oxide nanoparticle formation. In vitro studies confirmed that alginate mediated cellular iron chelation as exemplified by decreased cellular iron levels and ferritin expression. The effect was most profound for one alginate, namely ManLD. Ferritin expression reduced by 60% (p = 0.03) in cells challenged with ManLD and iron compared to cells challenged with iron alone. Cellular iron also decreased by 70% (p=0.001) when treated similarly. Furthermore, ManLD was shown to decrease intestinal iron absorption by 83% (p= 0.002) compared to an iron only control and was also able to suppress tumorigenesis in a murine intestinal cancer model, increasing median survival by 26 days (p = 0.007) compared to mice treated with vehicle alone. Conclusions Sodium alginate is an excellent candidate for sequestering luminal iron present in the gastrointestinal tract and in vivo shows promising anti-neoplastic activity. These results underpin the rationale in utilising these types of natural and safe bio-polymers for the prevention and treatment of gastrointestinal disease.
E21
Poster #2 NOVEL 3-HYDROXYPYRIDIN-4-ONE HEXADENTATE LIGAND-BASED POLYMERIC IRON CHELATOR: SYNTHESIS, CHARACTERIZATION AND ANTIMICROBIAL EVALUATIONTao Zhou, Yingjun Zhou, MSc, Xiaole Kong,...